525 related articles for article (PubMed ID: 12135371)
1. Peptides derived from BH3 domains of Bcl-2 family members: a comparative analysis of inhibition of Bcl-2, Bcl-x(L) and Bax oligomerization, induction of cytochrome c release, and activation of cell death.
Shangary S; Johnson DE
Biochemistry; 2002 Jul; 41(30):9485-95. PubMed ID: 12135371
[TBL] [Abstract][Full Text] [Related]
2. Sequence and helicity requirements for the proapoptotic activity of Bax BH3 peptides.
Shangary S; Oliver CL; Tillman TS; Cascio M; Johnson DE
Mol Cancer Ther; 2004 Nov; 3(11):1343-54. PubMed ID: 15542773
[TBL] [Abstract][Full Text] [Related]
3. Minimal BH3 peptides promote cell death by antagonizing anti-apoptotic proteins.
Moreau C; Cartron PF; Hunt A; Meflah K; Green DR; Evan G; Vallette FM; Juin P
J Biol Chem; 2003 May; 278(21):19426-35. PubMed ID: 12642586
[TBL] [Abstract][Full Text] [Related]
4. Bcl-XL protects BimEL-induced Bax conformational change and cytochrome C release independent of interacting with Bax or BimEL.
Yamaguchi H; Wang HG
J Biol Chem; 2002 Nov; 277(44):41604-12. PubMed ID: 12198137
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Bax-induced cytochrome c release from neural cell and brain mitochondria by dibucaine and propranolol.
Polster BM; Basañez G; Young M; Suzuki M; Fiskum G
J Neurosci; 2003 Apr; 23(7):2735-43. PubMed ID: 12684459
[TBL] [Abstract][Full Text] [Related]
6. Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics.
Letai A; Bassik MC; Walensky LD; Sorcinelli MD; Weiler S; Korsmeyer SJ
Cancer Cell; 2002 Sep; 2(3):183-92. PubMed ID: 12242151
[TBL] [Abstract][Full Text] [Related]
7. Structural biology of the Bcl-2 family of proteins.
Petros AM; Olejniczak ET; Fesik SW
Biochim Biophys Acta; 2004 Mar; 1644(2-3):83-94. PubMed ID: 14996493
[TBL] [Abstract][Full Text] [Related]
8. BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly.
Kuwana T; Bouchier-Hayes L; Chipuk JE; Bonzon C; Sullivan BA; Green DR; Newmeyer DD
Mol Cell; 2005 Feb; 17(4):525-35. PubMed ID: 15721256
[TBL] [Abstract][Full Text] [Related]
9. Direct addition of BimL to mitochondria does not lead to cytochrome c release.
Terradillos O; Montessuit S; Huang DC; Martinou JC
FEBS Lett; 2002 Jul; 522(1-3):29-34. PubMed ID: 12095614
[TBL] [Abstract][Full Text] [Related]
10. Anti-apoptotic Bcl-XL protein in complex with BH3 peptides of pro-apoptotic Bak, Bad, and Bim proteins: comparative molecular dynamics simulations.
Lama D; Sankararamakrishnan R
Proteins; 2008 Nov; 73(2):492-514. PubMed ID: 18452209
[TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis in prostate carcinoma cells by BH3 peptides which inhibit Bak/Bcl-2 interactions.
Finnegan NM; Curtin JF; Prevost G; Morgan B; Cotter TG
Br J Cancer; 2001 Jul; 85(1):115-21. PubMed ID: 11437412
[TBL] [Abstract][Full Text] [Related]
12. Bak BH3 peptides antagonize Bcl-xL function and induce apoptosis through cytochrome c-independent activation of caspases.
Holinger EP; Chittenden T; Lutz RJ
J Biol Chem; 1999 May; 274(19):13298-304. PubMed ID: 10224090
[TBL] [Abstract][Full Text] [Related]
13. Interaction between the antiapoptotic protein Nr-13 and cytochrome c. Antagonistic effect of the BH3 domain of Bax.
Moradi-Améli M; Lorca T; Ficheux D; di Pietro A; Gillet G
Biochemistry; 2002 Jul; 41(27):8540-50. PubMed ID: 12093270
[TBL] [Abstract][Full Text] [Related]
14. Bcl-X(L) and calyculin A prevent translocation of Bax to mitochondria during apoptosis.
Ganju N; Eastman A
Biochem Biophys Res Commun; 2002 Mar; 291(5):1258-64. PubMed ID: 11883953
[TBL] [Abstract][Full Text] [Related]
15. Regulation of apoptosis by BH3 domains in a cell-free system.
Cosulich SC; Worrall V; Hedge PJ; Green S; Clarke PR
Curr Biol; 1997 Dec; 7(12):913-20. PubMed ID: 9382837
[TBL] [Abstract][Full Text] [Related]
16. Structure-function analysis of Bcl-2 family proteins. Regulators of programmed cell death.
Reed JC; Zha H; Aime-Sempe C; Takayama S; Wang HG
Adv Exp Med Biol; 1996; 406():99-112. PubMed ID: 8910675
[TBL] [Abstract][Full Text] [Related]
17. A common binding site mediates heterodimerization and homodimerization of Bcl-2 family members.
Diaz JL; Oltersdorf T; Horne W; McConnell M; Wilson G; Weeks S; Garcia T; Fritz LC
J Biol Chem; 1997 Apr; 272(17):11350-5. PubMed ID: 9111042
[TBL] [Abstract][Full Text] [Related]
18. Distinct domains of Bcl-XL are involved in Bax and Bad antagonism and in apoptosis inhibition.
Zhou H; Hou Q; Chai Y; Hsu YT
Exp Cell Res; 2005 Oct; 309(2):316-28. PubMed ID: 16061221
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the anti-apoptotic mechanism of Bcl-B.
Zhai D; Ke N; Zhang H; Ladror U; Joseph M; Eichinger A; Godzik A; Ng SC; Reed JC
Biochem J; 2003 Nov; 376(Pt 1):229-36. PubMed ID: 12921534
[TBL] [Abstract][Full Text] [Related]
20. Molecular dynamics simulations of pro-apoptotic BH3 peptide helices in aqueous medium: relationship between helix stability and their binding affinities to the anti-apoptotic protein Bcl-X(L).
Lama D; Sankararamakrishnan R
J Comput Aided Mol Des; 2011 May; 25(5):413-26. PubMed ID: 21523491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
